OpenCravat aids cancer research by enabling scientists to identify and understand genetic mutations associated with cancer. By integrating various annotation tools, it allows researchers to predict the pathogenicity of variants, identify potentially actionable mutations, and understand the molecular mechanisms driving cancer. This enhances the ability to develop targeted therapies and personalize treatment plans.
